Federation des caisses Desjardins du Quebec’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.1M Buy
142,518
+7,259
+5% +$2.69M 0.17% 97
2026
Q1
$39.6M Sell
135,259
-10,111
-7% -$3.32M 0.14% 123
2025
Q4
$51M Sell
145,370
-7,226
-5% -$2.44M 0.19% 86
2025
Q3
$49.3M Buy
152,596
+14,306
+10% +$4.45M 0.19% 84
2025
Q2
$53.8M Sell
138,290
-6,998
-5% -$2.81M 0.24% 71
2025
Q1
$63.2M Buy
145,288
+69,936
+93% +$28.1M 0.31% 53
2024
Q4
$27.8M Sell
75,352
-1,083
-1% -$453K 0.14% 129
2024
Q3
$39.7M Buy
76,435
+1,810
+2% +$967K 0.2% 93
2024
Q2
$40.4M Buy
74,625
+998
+1% +$528K 0.22% 80
2024
Q1
$35.1M Buy
73,627
+5,442
+8% +$2.71M 0.25% 88
2023
Q4
$32.2M Buy
68,185
+3,746
+6% +$1.73M 0.3% 70
2023
Q3
$28.1M Sell
64,439
-20,697
-24% -$9.39M 0.29% 75
2023
Q2
$37.8M Sell
85,136
-4,174
-5% -$1.93M 0.37% 56
2023
Q1
$41.1M Sell
89,310
-4,932
-5% -$2.35M 0.45% 51
2022
Q4
$48.3M Sell
94,242
-4,286
-4% -$2.18M 0.57% 40
2022
Q3
$44.8M Buy
98,528
+1,733
+2% +$829K 0.53% 44
2022
Q2
$46.7M Sell
96,795
-11,621
-11% -$5.75M 0.52% 46
2022
Q1
$53.3M Buy
108,416
+9,374
+9% +$4.28M 0.51% 47
2021
Q4
$45.9M Buy
99,042
+11,895
+14% +$5M 0.45% 51
2021
Q3
$32.5M Buy
87,147
+966
+1% +$367K 0.34% 61
2021
Q2
$32.9M Sell
86,181
-3,200
-4% -$1.22M 0.33% 63
2021
Q1
$32.1M Buy
89,381
+7,431
+9% +$2.39M 0.35% 61
2020
Q4
$26.3M Sell
81,950
-2,611
-3% -$801K 0.32% 67
2020
Q3
$22.8M Buy
84,561
+5,436
+7% +$1.46M 0.32% 70
2020
Q2
$20.9M Buy
79,125
+787
+1% +$210K 0.31% 74
2020
Q1
$18M Buy
78,338
+135
+0.2% +$36.8K 0.31% 68
2019
Q4
$23.6M Buy
78,203
+7,546
+11% +$2.08M 0.33% 63
2019
Q3
$17M Buy
70,657
+13,731
+24% +$3.76M 0.25% 75
2019
Q2
$16M Sell
56,926
-1,050
-2% -$287K 0.24% 79
2019
Q1
$16.6M Buy
57,976
+1,035
+2% +$299K 0.25% 75
2018
Q4
$15M Sell
56,941
-108
-0.2% -$29.7K 0.25% 76
2018
Q3
$15.7M Sell
57,049
-6,091
-10% -$1.58M 0.23% 79
2018
Q2
$15M Sell
63,140
-3,864
-6% -$895K 0.23% 81
2018
Q1
$14.7M Sell
67,004
-821
-1% -$193K 0.23% 81
2017
Q4
$15.2M Sell
67,825
-3,784
-5% -$806K 0.23% 87
2017
Q3
$13.6M Buy
71,609
+95
+0.1% +$18.1K 0.22% 92
2017
Q2
$13.5M Sell
71,514
-9,358
-12% -$1.68M 0.22% 92
2017
Q1
$13.4M Buy
+80,872
New +$12.9M 0.25% 77

Other funds holding ELV

Federation des caisses Desjardins du Quebec's ELV Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Elevance Health (ELV) stake by 5.4% in Q2 2026, buying an estimated $2.69M and bringing the position to 142,518 shares worth $55.1M. The position accounts for 0.17% of the portfolio, ranked #97.

Federation des caisses Desjardins du Quebec first reported a position in ELV in Q1 2017 and has held it in 38 quarters since. The position peaked at $63.2M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 142,518 shares of Elevance Health worth $55.1M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 7,259 Elevance Health shares in Q2 2026, an estimated $2.69M.
  • Elevance Health made up 0.17% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #97 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Elevance Health in Q1 2017 and has held it in 38 quarters since.
  • Federation des caisses Desjardins du Quebec's Elevance Health position peaked at $63.2M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.